Substrate of CYP3A and inhibitor of P-glycoprotein

Novel DprE1 inhibitor, killing M. tuberculosis

Click chemistry tool molecule in probing peptidoglycan (PG)

Novel Dual PROTAC for Simultaneous Degradation of EGFR and PARP

Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV

Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV

Oral non-opioid anti-tussive agent for treatment of cough

Inhibitor of the growth of estrogen receptor-presenting breast cancers

Novel potent PTHR1 antagonist

Novel selective PPARγ modulator, resulting in robust plasma glucose reductions with excellent DMPK profiles

Novel potent orally active hepcidin production inhibitor

Novel and orally bioavailable PTHR1 antagonist

Novel non-macrolide GPR38 agonist

Novel potent orally active hepcidin production inhibitor

Novel Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease

Pathogen motility inhibitor of EcDsbA

Non-toxic human papillomavirus E6 inhibitor

Novel Plasmodium falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitor (Pfalcip cells: 0.0018 μM)

Novel potent inhibitor of dihydroorotate dehydrogenase (DHODH)

Novel potent Dihydroorotate Dehydrogenase (DHODH) inhibitor

Novel selective mGlu5 receptor negative allosteric modulator (NAM) with potent antidepressant and antimanic activity

Agonist of S1P receptors